RS50025B - Farmaceutski preparati koji mogu da budu gelirani - Google Patents

Farmaceutski preparati koji mogu da budu gelirani

Info

Publication number
RS50025B
RS50025B YUP-666/00A YU66600A RS50025B RS 50025 B RS50025 B RS 50025B YU 66600 A YU66600 A YU 66600A RS 50025 B RS50025 B RS 50025B
Authority
RS
Serbia
Prior art keywords
weight
gelled
pharmaceutical compositions
compositions capable
active substance
Prior art date
Application number
YUP-666/00A
Other languages
English (en)
Inventor
Domenico Fanara
Henri Vranckx
Michel DELEERS
Original Assignee
Ucb S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb S.A., filed Critical Ucb S.A.,
Publication of YU66600A publication Critical patent/YU66600A/sh
Publication of RS50025B publication Critical patent/RS50025B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Fluidni farmaceutski preparat koji obezbeđuje kontrolisao oslobađanje bar jedne aktivne supstance i koji obuhvata: a) terapeutski efikasnu količinu bar jedne aktivne supstance, b) od 3 do 55 masenih % fosfolipida, c) od 16 do 72 masenih % fannaceutski prihvatljivog rastvarača, i d) od 4 do 52 masenih % masne kiseline, pomenuti preparat ima svojstvo trenutnog geliranja u prisustvu vodene faze. Prijava sadži još 13 zahteva.
YUP-666/00A 1998-04-30 1999-04-16 Farmaceutski preparati koji mogu da budu gelirani RS50025B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9800329A BE1011899A6 (fr) 1998-04-30 1998-04-30 Compositions pharmaceutiques gelifiables utilisables.

Publications (2)

Publication Number Publication Date
YU66600A YU66600A (sh) 2003-04-30
RS50025B true RS50025B (sr) 2008-11-28

Family

ID=3891230

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-666/00A RS50025B (sr) 1998-04-30 1999-04-16 Farmaceutski preparati koji mogu da budu gelirani

Country Status (26)

Country Link
US (3) US6464987B1 (sr)
EP (2) EP1073415B1 (sr)
JP (2) JP2002513748A (sr)
KR (1) KR100567975B1 (sr)
CN (1) CN1183901C (sr)
AT (2) ATE219659T1 (sr)
AU (2) AU3708599A (sr)
BE (1) BE1011899A6 (sr)
BG (1) BG64723B1 (sr)
BR (1) BR9910066A (sr)
CA (1) CA2330500C (sr)
DE (2) DE69927963T2 (sr)
DK (1) DK1073415T3 (sr)
EA (1) EA002530B1 (sr)
ES (2) ES2249891T3 (sr)
HK (1) HK1033263A1 (sr)
HU (1) HU226556B1 (sr)
ID (1) ID26221A (sr)
IL (1) IL139113A0 (sr)
IS (1) IS2354B (sr)
NO (1) NO20005431L (sr)
NZ (1) NZ507707A (sr)
RS (1) RS50025B (sr)
TR (1) TR200003158T2 (sr)
WO (2) WO1999056725A1 (sr)
ZA (1) ZA200005915B (sr)

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
US11026768B2 (en) 1998-10-08 2021-06-08 Align Technology, Inc. Dental appliance reinforcement
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
CN1607937A (zh) * 2001-10-19 2005-04-20 爱德士实验室公司 用于药理活性化合物的可控释放的可注射组合物
EP1485066B1 (fr) * 2002-03-12 2016-09-21 Ethypharm Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
FR2837099B1 (fr) * 2002-03-12 2005-03-18 Ethypharm Sa Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US8435942B2 (en) * 2002-05-31 2013-05-07 Transdermal Biotechnology, Inc. Methods for formulating stabilized insulin compositions
US20050031650A1 (en) * 2002-08-26 2005-02-10 Ethypharm Composition with gelling properties for the sustained delivery of bioactive substances
DE10255195A1 (de) 2002-11-27 2004-06-09 Lipoid Gmbh Micellare wasserlösliche Konzentrate
EP1682091B1 (en) * 2003-11-07 2017-03-29 Camurus Ab Compositions of lipids and cationic peptides
US20070232695A1 (en) * 2004-01-28 2007-10-04 Collegium Pharmaceutical, Inc. Gelled Periodontal Anesthetic Preparation
US9492245B2 (en) 2004-02-27 2016-11-15 Align Technology, Inc. Method and system for providing dynamic orthodontic assessment and treatment profiles
NZ551990A (en) * 2004-06-04 2011-01-28 Camurus Ab Liquid depot formulations
GB0412530D0 (en) * 2004-06-04 2004-07-07 Camurus Ab Formulation
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
JP5144267B2 (ja) * 2004-10-28 2013-02-13 アイデックス ラボラトリーズ，インコーポレイティド 医薬活性化合物を制御して搬送するための組成物
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
DE602005026998D1 (de) * 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
EP1843746B1 (en) * 2005-01-14 2011-03-16 Camurus Ab Somatostatin analogue formulations
US9649382B2 (en) * 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
WO2006075125A1 (en) * 2005-01-14 2006-07-20 Camurus Ab GnRH ANALOGUE FORMULATIONS
ES2343641T3 (es) * 2005-01-14 2010-08-05 Camurus Ab Formulaciones bioadhesivas topicas.
CA2595385C (en) * 2005-01-21 2011-01-25 Camurus Ab Pharmaceutical lipid compositions
EP1888031B1 (en) * 2005-06-06 2013-01-23 Camurus Ab Glp-1 analogue formulations
SE531318C2 (sv) * 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur
US7878805B2 (en) 2007-05-25 2011-02-01 Align Technology, Inc. Tabbed dental appliance
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
CA2698628A1 (fr) * 2007-09-12 2009-04-16 Galderma Research & Development Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant
US8738394B2 (en) 2007-11-08 2014-05-27 Eric E. Kuo Clinical data file
FR2926996B1 (fr) 2008-01-31 2013-06-21 Ethypharm Sa Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
US8108189B2 (en) 2008-03-25 2012-01-31 Align Technologies, Inc. Reconstruction of non-visible part of tooth
US8092215B2 (en) 2008-05-23 2012-01-10 Align Technology, Inc. Smile designer
US9492243B2 (en) 2008-05-23 2016-11-15 Align Technology, Inc. Dental implant positioning
US8172569B2 (en) 2008-06-12 2012-05-08 Align Technology, Inc. Dental appliance
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US20110229565A1 (en) 2008-09-17 2011-09-22 Karp Jeffrey M Drug Delivery Composition Comprising a Self-Assembled Gelator
US8152518B2 (en) 2008-10-08 2012-04-10 Align Technology, Inc. Dental positioning appliance having metallic portion
US8292617B2 (en) 2009-03-19 2012-10-23 Align Technology, Inc. Dental wire attachment
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
US8362013B2 (en) * 2009-04-30 2013-01-29 Abbvie Inc. Salt of ABT-263 and solid-state forms thereof
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263
US20100280031A1 (en) * 2009-04-30 2010-11-04 Paul David Lipid formulation of apoptosis promoter
US20100297194A1 (en) * 2009-04-30 2010-11-25 Nathaniel Catron Formulation for oral administration of apoptosis promoter
TWI540132B (zh) * 2009-06-08 2016-07-01 亞培公司 Ｂｃｌ-２族群抑制劑之口服醫藥劑型
TWI532484B (zh) * 2009-06-08 2016-05-11 艾伯維有限公司 包含凋亡促進劑之固態分散劑
PL2387391T3 (pl) * 2009-07-24 2017-09-29 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Sposób otrzymywania ciekłej kompozycji stosowalnej w postaci piany na skórę oraz kompozycja do aplikowania miejscowego
US8765031B2 (en) 2009-08-13 2014-07-01 Align Technology, Inc. Method of forming a dental appliance
AU2010336518B2 (en) * 2009-12-22 2014-03-06 Abbvie Inc. ABT-263 capsule
WO2011109472A1 (en) * 2010-03-02 2011-09-09 Imagenetix, Inc. Compositions comprising myristic acid and uses thereof
US9211166B2 (en) 2010-04-30 2015-12-15 Align Technology, Inc. Individualized orthodontic treatment index
US9241774B2 (en) 2010-04-30 2016-01-26 Align Technology, Inc. Patterned dental positioning appliance
WO2012040623A2 (en) 2010-09-24 2012-03-29 The Brigham And Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
UA113500C2 (xx) 2010-10-29 2017-02-10 Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
EP2685962A1 (en) 2011-03-17 2014-01-22 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
WO2012144943A1 (en) * 2011-04-18 2012-10-26 Lipidor Ab Liquid carrier for oral delivery of a pharmacologically active agent
US9403238B2 (en) 2011-09-21 2016-08-02 Align Technology, Inc. Laser cutting
US8716363B2 (en) * 2011-09-28 2014-05-06 Globus Medical, Inc. Biodegradable putty compositions and implant devices, methods, and kits relating to the same
EP2787975B1 (en) * 2011-12-05 2017-10-04 Camurus AB Robust controlled-release formulations
BR112014014130A2 (pt) * 2011-12-21 2017-06-13 Hills Pet Nutrition Inc tratamento ou redução de condições dentárias com ésteres de ascorbilo
US9375300B2 (en) 2012-02-02 2016-06-28 Align Technology, Inc. Identifying forces on a tooth
US9220580B2 (en) 2012-03-01 2015-12-29 Align Technology, Inc. Determining a dental treatment difficulty
CN104427976B (zh) * 2012-05-10 2018-04-24 佩因拉佛姆有限公司 疏水的活性成分的储库制剂及其制备方法
US9414897B2 (en) 2012-05-22 2016-08-16 Align Technology, Inc. Adjustment of tooth position in a virtual dental model
MA37672A1 (fr) 2012-05-25 2016-07-29 Camurus Ab Formulation d'agoniste des récepteurs à la somatostatine
US9937164B2 (en) 2012-07-26 2018-04-10 Camurus Ab Opioid formulations
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US10449016B2 (en) 2014-09-19 2019-10-22 Align Technology, Inc. Arch adjustment appliance
US9610141B2 (en) 2014-09-19 2017-04-04 Align Technology, Inc. Arch expanding appliance
US9744001B2 (en) 2014-11-13 2017-08-29 Align Technology, Inc. Dental appliance with cavity for an unerupted or erupting tooth
US10504386B2 (en) 2015-01-27 2019-12-10 Align Technology, Inc. Training method and system for oral-cavity-imaging-and-modeling equipment
US9610242B2 (en) * 2015-08-18 2017-04-04 Concept Labs, Inc. Water-gel emulsion compositions and methods
JP7121654B2 (ja) * 2015-10-08 2022-08-18 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 被包した薬剤の送達のための安定化させた集合ナノ構造体
US11931222B2 (en) 2015-11-12 2024-03-19 Align Technology, Inc. Dental attachment formation structures
US11554000B2 (en) 2015-11-12 2023-01-17 Align Technology, Inc. Dental attachment formation structure
US11596502B2 (en) 2015-12-09 2023-03-07 Align Technology, Inc. Dental attachment placement structure
US11103330B2 (en) 2015-12-09 2021-08-31 Align Technology, Inc. Dental attachment placement structure
JP7169880B2 (ja) 2016-05-06 2022-11-11 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 軟骨へのカプセル化薬剤の制御送達のための二成分型自己集合ゲル
EP3471653B1 (en) 2016-06-17 2021-12-22 Align Technology, Inc. Orthodontic appliance performance monitor
EP3471599A4 (en) 2016-06-17 2020-01-08 Align Technology, Inc. INTRAORAL DEVICES WITH SENSOR
CN113499159B (zh) 2016-07-27 2023-02-03 阿莱恩技术有限公司 具有牙科诊断能力的口内扫描仪
EP4295748A3 (en) 2016-11-04 2024-03-27 Align Technology, Inc. Methods and apparatuses for dental images
US11273011B2 (en) 2016-12-02 2022-03-15 Align Technology, Inc. Palatal expanders and methods of expanding a palate
WO2018102770A1 (en) 2016-12-02 2018-06-07 Align Technology, Inc. Force control, stop mechanism, regulating structure of removable arch adjustment appliance
WO2018102702A1 (en) 2016-12-02 2018-06-07 Align Technology, Inc. Dental appliance features for speech enhancement
CA3043049A1 (en) 2016-12-02 2018-06-07 Align Technology, Inc. Methods and apparatuses for customizing rapid palatal expanders using digital models
US10548700B2 (en) 2016-12-16 2020-02-04 Align Technology, Inc. Dental appliance etch template
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
US10779718B2 (en) 2017-02-13 2020-09-22 Align Technology, Inc. Cheek retractor and mobile device holder
US10613515B2 (en) 2017-03-31 2020-04-07 Align Technology, Inc. Orthodontic appliances including at least partially un-erupted teeth and method of forming them
AU2018266131B2 (en) 2017-05-08 2021-07-29 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
US11045283B2 (en) 2017-06-09 2021-06-29 Align Technology, Inc. Palatal expander with skeletal anchorage devices
US11996181B2 (en) 2017-06-16 2024-05-28 Align Technology, Inc. Automatic detection of tooth type and eruption status
WO2019005808A1 (en) 2017-06-26 2019-01-03 Align Technology, Inc. BIOCAPTOR PERFORMANCE INDICATOR FOR INTRABUCCAL DEVICES
US10885521B2 (en) 2017-07-17 2021-01-05 Align Technology, Inc. Method and apparatuses for interactive ordering of dental aligners
CN111107806B (zh) 2017-07-21 2022-04-19 阿莱恩技术有限公司 颚轮廓锚固
US10517482B2 (en) 2017-07-27 2019-12-31 Align Technology, Inc. Optical coherence tomography for orthodontic aligners
EP3658070A1 (en) 2017-07-27 2020-06-03 Align Technology, Inc. Tooth shading, transparency and glazing
WO2019035979A1 (en) 2017-08-15 2019-02-21 Align Technology, Inc. EVALUATION AND CALCULATION OF BUCCAL CORRIDOR
US11123156B2 (en) 2017-08-17 2021-09-21 Align Technology, Inc. Dental appliance compliance monitoring
US10813720B2 (en) 2017-10-05 2020-10-27 Align Technology, Inc. Interproximal reduction templates
WO2019084326A1 (en) 2017-10-27 2019-05-02 Align Technology, Inc. OTHER BORE ADJUSTMENT STRUCTURES
EP3703608B1 (en) 2017-10-31 2023-08-30 Align Technology, Inc. Determination of a dental appliance having selective occlusal loading and controlled intercuspation
CN115252177A (zh) 2017-11-01 2022-11-01 阿莱恩技术有限公司 自动治疗规划
US11534974B2 (en) 2017-11-17 2022-12-27 Align Technology, Inc. Customized fabrication of orthodontic retainers based on patient anatomy
WO2019108978A1 (en) 2017-11-30 2019-06-06 Align Technology, Inc. Sensors for monitoring oral appliances
US11432908B2 (en) 2017-12-15 2022-09-06 Align Technology, Inc. Closed loop adaptive orthodontic treatment methods and apparatuses
US10980613B2 (en) 2017-12-29 2021-04-20 Align Technology, Inc. Augmented reality enhancements for dental practitioners
EP3743010B1 (en) 2018-01-26 2022-01-12 Align Technology, Inc. Diagnostic intraoral scanning and tracking
US11937991B2 (en) 2018-03-27 2024-03-26 Align Technology, Inc. Dental attachment placement structure
CN108498376B (zh) * 2018-04-02 2020-11-13 榛硕（武汉）智能科技有限公司 一种甲基硅油乳液及其制备方法
KR20200141498A (ko) 2018-04-11 2020-12-18 얼라인 테크널러지, 인크. 해제 가능한 구개 확장기
CN113825495A (zh) 2018-10-11 2021-12-21 阿利维奥治疗学股份有限公司 用于智能释放的不可注射水凝胶调配物
CN113164402A (zh) 2018-10-15 2021-07-23 希普拉有限公司 药物制剂
EP3848016A1 (en) * 2020-01-08 2021-07-14 3M Innovative Properties Company Oral care composition containing fatty acid components for treating caries
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics
JP7092922B1 (ja) * 2021-06-11 2022-06-28 キユーピー株式会社 製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230899A (en) * 1985-08-07 1993-07-27 Smithkline Beecham Corporation Methods and compositions for making liposomes
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5230895A (en) * 1990-05-01 1993-07-27 Copley Pharmaceutical Inc. Sustained released delivery system for use in the periodontal pocket
US5567456A (en) * 1991-11-04 1996-10-22 Creative Products Inc. Of Rossville Food release compositions with organic fluidizing agents
CA2082561A1 (en) * 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
GB9224010D0 (en) * 1992-11-16 1993-01-06 Phares Pharma Holland Composition and method
ATE195866T1 (de) 1993-07-28 2000-09-15 Pharmaderm Lab Ltd Zweiphasige multilamellare lipidvesikel
WO1996010389A1 (de) * 1994-09-30 1996-04-11 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische zusammensetzung
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.

Also Published As

Publication number Publication date
CA2330500C (fr) 2009-06-16
JP2002513749A (ja) 2002-05-14
WO1999056725A1 (fr) 1999-11-11
BE1011899A6 (fr) 2000-02-01
EP1073415A1 (fr) 2001-02-07
ATE307569T1 (de) 2005-11-15
TR200003158T2 (tr) 2001-03-21
KR100567975B1 (ko) 2006-04-07
NZ507707A (en) 2002-05-31
DE69927963T2 (de) 2006-06-29
IS5669A (is) 2000-10-17
US6818224B2 (en) 2004-11-16
DE69927963D1 (de) 2005-12-01
BG64723B1 (bg) 2006-01-31
AU3708599A (en) 1999-11-23
EA200001125A1 (ru) 2001-04-23
IL139113A0 (en) 2001-11-25
ID26221A (id) 2000-12-07
HUP0101580A3 (en) 2002-10-28
EP1073414A1 (fr) 2001-02-07
NO20005431L (no) 2000-12-19
BR9910066A (pt) 2000-12-26
CA2330500A1 (fr) 1999-11-11
HUP0101580A2 (hu) 2002-03-28
HU226556B1 (en) 2009-03-30
EP1073414B1 (fr) 2002-06-26
DE69901951T2 (de) 2002-11-28
HK1033263A1 (en) 2001-08-24
WO1999056726A1 (fr) 1999-11-11
BG104872A (bg) 2001-07-31
DK1073415T3 (da) 2006-03-06
AU4030899A (en) 1999-11-23
DE69901951D1 (de) 2002-08-01
NO20005431D0 (no) 2000-10-27
IS2354B (is) 2008-04-15
US6464987B1 (en) 2002-10-15
KR20010043000A (ko) 2001-05-25
JP2002513748A (ja) 2002-05-14
ES2178430T3 (es) 2002-12-16
CN1183901C (zh) 2005-01-12
YU66600A (sh) 2003-04-30
ATE219659T1 (de) 2002-07-15
ZA200005915B (en) 2001-10-23
EA002530B1 (ru) 2002-06-27
US6471970B1 (en) 2002-10-29
CN1301147A (zh) 2001-06-27
US20030199477A1 (en) 2003-10-23
ES2249891T3 (es) 2006-04-01
AU738455B2 (en) 2001-09-20
EP1073415B1 (fr) 2005-10-26

Similar Documents

Publication Publication Date Title
RS50025B (sr) Farmaceutski preparati koji mogu da budu gelirani
HRP20010243B1 (en) Compositions containing diphosphonic acids
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
NO934284D0 (no) Farmas!ytisk preparat inneholdende et definert lipidsystem
IL111647A (en) Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation
NO20030897L (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
BR0107869A (pt) Composições farmacêuticas eletrogiradas
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
DK0722313T3 (da) Viskoelastiske sammensætninger af fluorerede organiske forbindelser
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
SE9202066D0 (sv) Prokaterol-haltigt preparat foer paafoering paa huden
JP2003095985A (ja) 血行促進組成物
ES2195538T3 (es) Composicion farmaceutica que comprende una combinacion de isomeros dextro y levo de sotalol.
US4404198A (en) Phenyl Salicylate as a topical anti-inflammatory
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
PT1005275E (pt) Formulacao inibidora e profilactica
DK0521353T3 (da) Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf
MEP18508A (en) Pharmaceutical composition and preparation thereof
KR890011594A (ko) 4-아로일이미다졸-2-온의 제약 조성물
CA2414921A1 (en) Use of diclofenac for treatment of burns
CA1142090A (en) Topical anti-inflammatory composition
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
KR970032876A (ko) 간장질환 치료용 의약 조성물
KR960021036A (ko) 콜치신을 유효성분으로 함유하는 항간독성 조성물 및 그 제조방법
AU2003264113A1 (en) Composition and use thereof as a pharmaceutical or cosmetic formulation for external application